Burcon NutraScience Statistics
Total Valuation
BRCNF has a market cap or net worth of 14.12 million. The enterprise value is 29.61 million.
| Market Cap | 14.12M |
| Enterprise Value | 29.61M |
Important Dates
The last earnings date was Wednesday, November 12, 2025.
| Earnings Date | Nov 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 12.69M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +59.51% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 15.51% |
| Owned by Institutions (%) | 0.10% |
| Float | 7.64M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 24.47 |
| PB Ratio | 152.29 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -3.71 |
| EV / Sales | 50.99 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -5.23 |
Financial Position
The company has a current ratio of 0.25, with a Debt / Equity ratio of 179.66.
| Current Ratio | 0.25 |
| Quick Ratio | 0.19 |
| Debt / Equity | 179.66 |
| Debt / EBITDA | n/a |
| Debt / FCF | -2.94 |
| Interest Coverage | -4.71 |
Financial Efficiency
Return on equity (ROE) is -1,245.82% and return on invested capital (ROIC) is -35.83%.
| Return on Equity (ROE) | -1,245.82% |
| Return on Assets (ROA) | -33.38% |
| Return on Invested Capital (ROIC) | -35.83% |
| Return on Capital Employed (ROCE) | -67.18% |
| Revenue Per Employee | 38,467 |
| Profits Per Employee | -532,109 |
| Employee Count | 15 |
| Asset Turnover | 0.05 |
| Inventory Turnover | 14.29 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +2.41% in the last 52 weeks. The beta is 2.82, so BRCNF's price volatility has been higher than the market average.
| Beta (5Y) | 2.82 |
| 52-Week Price Change | +2.41% |
| 50-Day Moving Average | 1.54 |
| 200-Day Moving Average | 1.57 |
| Relative Strength Index (RSI) | 32.69 |
| Average Volume (20 Days) | 3,279 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BRCNF had revenue of 577,008 and -7.98 million in losses. Loss per share was -0.75.
| Revenue | 577,008 |
| Gross Profit | -2.84M |
| Operating Income | -6.54M |
| Pretax Income | -7.98M |
| Net Income | -7.98M |
| EBITDA | -6.37M |
| EBIT | -6.54M |
| Loss Per Share | -0.75 |
Balance Sheet
The company has 1.26 million in cash and 16.65 million in debt, giving a net cash position of -15.39 million.
| Cash & Cash Equivalents | 1.26M |
| Total Debt | 16.65M |
| Net Cash | -15.39M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 92,699 |
| Book Value Per Share | 0.01 |
| Working Capital | -5.89M |
Cash Flow
In the last 12 months, operating cash flow was -5.11 million and capital expenditures -553,474, giving a free cash flow of -5.66 million.
| Operating Cash Flow | -5.11M |
| Capital Expenditures | -553,474 |
| Free Cash Flow | -5.66M |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | -1,133.53% |
| Pretax Margin | -1,383.28% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BRCNF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -59.51% |
| Shareholder Yield | -59.51% |
| Earnings Yield | -56.54% |
| FCF Yield | -40.10% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 11, 2025. It was a reverse split with a ratio of 0.05.
| Last Split Date | Jun 11, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.05 |
Scores
BRCNF has an Altman Z-Score of -9.97 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -9.97 |
| Piotroski F-Score | 2 |